SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-097943
Filing Date
2016-02-18
Accepted
2016-02-18 11:10:58
Documents
1
Period of Report
2016-02-18

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3059
  Complete submission text file 0001104659-16-097943.txt   4437
Mailing Address C/O ALLIQUA, INC. 850 THIRD AVENUE, SUITE 1801 NEW YORK NY 10022
Business Address
SAPIRSTEIN JAMES (Reporting) CIK: 0001559509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36856 | Film No.: 161436443

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations